HealthLynked Corp.
HLYK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3,008 | $5,722 | $5,858 | $9,198 |
| % Growth | -47.4% | -2.3% | -36.3% | – |
| Cost of Goods Sold | $96 | $3,374 | $463 | $3,020 |
| Gross Profit | $2,912 | $2,349 | $5,395 | $6,178 |
| % Margin | 96.8% | 41% | 92.1% | 67.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $5,034 | $6,855 | $7,913 | $8,045 |
| SG&A Expenses | $3,039 | $3,623 | $7,913 | $8,045 |
| Sales & Mktg Exp. | -$1,995 | -$3,231 | $0 | $0 |
| Other Operating Expenses | $4,551 | $2,877 | $3,396 | $3,177 |
| Operating Expenses | $7,590 | $6,500 | $11,309 | $11,222 |
| Operating Income | -$4,678 | -$4,152 | -$5,914 | -$5,043 |
| % Margin | -155.5% | -72.6% | -100.9% | -54.8% |
| Other Income/Exp. Net | -$1,454 | $538 | $592 | -$5,657 |
| Pre-Tax Income | -$6,131 | -$3,614 | -$8,067 | -$10,700 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$6,131 | -$1,012 | -$8,816 | -$10,412 |
| % Margin | -203.8% | -17.7% | -150.5% | -113.2% |
| EPS | -2.18 | -0.39 | -3.62 | -4.63 |
| % Growth | -459% | 89.2% | 21.8% | – |
| EPS Diluted | -2.18 | -0.39 | -3.62 | -4.63 |
| Weighted Avg Shares Out | 2,815 | 2,629 | 2,434 | 2,247 |
| Weighted Avg Shares Out Dil | 2,815 | 2,629 | 2,434 | 2,247 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $78 | $0 |
| Interest Expense | $1,484 | $512 | $78 | $19 |
| Depreciation & Amortization | $283 | $352 | $829 | $828 |
| EBITDA | -$4,364 | -$2,750 | -$7,050 | -$9,853 |
| % Margin | -145.1% | -48.1% | -120.3% | -107.1% |